Upconversion nanoparticles and their potential in the realm of biomedical sciences and theranostics

1. Feynman RP (2011) There’s plenty of room at the bottom. Reson 16:890–905. https://doi.org/10.1007/S12045-011-0109-X10.1007/S12045-011-0109-X ↗

2. Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F (2020) The history of nanoscience and nanotechnology: from chemical–physical applications to nanomedicine. Molecules 25:112. https://doi.org/10.3390/MOLECULES2501011210.3390/MOLECULES25010112 ↗

3. Sirkka N, Lyytikäinen A, Savukoski T, Soukka T (2016) Upconverting nanophosphors as reporters in a highly sensitive heterogeneous immunoassay for cardiac troponin I. Anal Chim Acta 925:82–87. https://doi.org/10.1016/J.ACA.2016.04.02710.1016/J.ACA.2016.04.027 ↗

4. Li Z, Zhang Y, La H, Zhu R, El-Banna G, Wei Y, Han G (2015) Upconverting NIR photons for bioimaging. Nanomater 5:2148–2168. https://doi.org/10.3390/NANO504214810.3390/NANO5042148 ↗

5. Shen J, Chen G, Vu AM, Fan W, Bilsel OS, Chang CC, Han G (2013) Engineering the upconversion nanoparticle excitation wavelength: cascade sensitization of tri-doped upconversion colloidal nanoparticles at 800 nm. Adv Opt Mater 1:644–650. https://doi.org/10.1002/ADOM.20130016010.1002/ADOM.201300160 ↗

6. Gulzar A, Xu J, Yang D, Xu L, He F, Gai S, Yang P (2018) Nano-graphene oxide-UCNP-Ce6 covalently constructed nanocomposites for NIR-mediated bioimaging and PTT/PDT combinatorial therapy. Dalt Trans 47:3931–3939. https://doi.org/10.1039/C7DT04141A10.1039/C7DT04141A ↗

7. Wen S et al (2018) Advances in highly doped upconversion nanoparticles. Nat Commun 2018 9:1 9:1–1210.1038/s41467-018-04813-5 ↗

8. Du K, Feng J, Gao X, Zhang H (2022) Nanocomposites based on lanthanide-doped upconversion nanoparticles: diverse designs and applications. Light Sci Appl 2022 11:1 11:1–2310.1038/s41377-022-00871-z ↗

9. Jethva P, Momin M, Khan T, Omri A (2022) Lanthanide-doped upconversion luminescent nanoparticles-evolving role in bioimaging, biosensing, and drug delivery. Materials (Basel) 1510.3390/ma15072374 ↗

10. Smith AM, Mancini MC, Nie S (2009) Bioimaging: second window for in vivo imaging. Nat Nanotechnol 4:710–711. https://doi.org/10.1038/NNANO.2009.32610.1038/NNANO.2009.326 ↗

11. Xu S, Xu S, Zhu Y, Xu W, Zhou P, Zhou C, Dong B, Song H (2014) A novel upconversion, fluorescence resonance energy transfer biosensor (FRET) for sensitive detection of lead ions in human serum. Nanoscale 6:12573–12579. https://doi.org/10.1039/C4NR03092C10.1039/C4NR03092C ↗

12. Thakur MK, Gupta A, Fakhri MY, Chen RS, Wu CT, Lin KH, Chattopadhyay S (2019) Optically coupled engineered upconversion nanoparticles and graphene for a high responsivity broadband photodetector. Nanoscale 11:9716–9725. https://doi.org/10.1039/C8NR10280E10.1039/C8NR10280E ↗

13. Johnson NJJ, Sangeetha NM, Boyer JC, Van Veggel FCJM (2010) Facile ligand-exchange with polyvinylpyrrolidone and subsequent silica coating of hydrophobic upconverting β-NaYF4: Yb 3+/Er3+ nanoparticles. Nanoscale 2:771–777. https://doi.org/10.1039/B9NR00379G10.1039/B9NR00379G ↗

14. Xiong LQ, Chen ZG, Yu MX, Li FY, Liu C, Huang CH (2009) Synthesis, characterization, and in vivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors. Biomaterials 30:5592–5600. https://doi.org/10.1016/J.BIOMATERIALS.2009.06.01510.1016/J.BIOMATERIALS.2009.06.015 ↗

15. Ansari AA, Parchur AK, Thorat ND, Chen G (2021) New advances in pre-clinical diagnostic imaging perspectives of functionalized upconversion nanoparticle-based nanomedicine. Coord Chem Rev 440:213971. https://doi.org/10.1016/J.CCR.2021.21397110.1016/J.CCR.2021.213971 ↗

16. DaCosta MV, Doughan S, Han Y, Krull UJ (2014) Lanthanide upconversion nanoparticles and applications in bioassays and bioimaging: a review. Anal Chim Acta 832:1–33. https://doi.org/10.1016/J.ACA.2014.04.03010.1016/J.ACA.2014.04.030 ↗

17. Lee J, Lee H, Kang M, Baday M, Lee SH (2022) High spatial and temporal resolution using upconversion nanoparticles and femtosecond pulsed laser in single particle tracking. Curr Appl Phys 44:40–45. https://doi.org/10.1016/J.CAP.2022.09.00210.1016/J.CAP.2022.09.002 ↗

18. Del Rosal B, Jaque D (2019) Upconversion nanoparticles for in vivo applications: limitations and future perspectives. Methods Appl Fluoresc 7:022001. https://doi.org/10.1088/2050-6120/AB029F10.1088/2050-6120/AB029F ↗

19. Joubert MF (1999) Photon avalanche upconversion in rare earth laser materials. Opt Mater (Amst) 11:181–203. https://doi.org/10.1016/S0925-3467(98)00043-310.1016/S0925-3467(98)00043-3 ↗

20. Wang M, Abbineni G, Clevenger A, Mao C, Xu S (2011) Upconversion nanoparticles: synthesis, surface modification and biological applications. Nanomed Nanotechnol Biol Med 7:710–729. https://doi.org/10.1016/J.NANO.2011.02.01310.1016/J.NANO.2011.02.013 ↗

21. Bloembergen N (1959) Solid state infrared quantum counters. Phys Rev Lett 2:84–85. https://doi.org/10.1103/PHYSREVLETT.2.8410.1103/PHYSREVLETT.2.84 ↗

22. Wilhelm S, Kaiser M, Würth C, Heiland J, Carrillo-Carrion C, Muhr V, Wolfbeis OS, Parak WJ, Resch-Genger U, Hirsch T (2015) Water dispersible upconverting nanoparticles: effects of surface modification on their luminescence and colloidal stability. Nanoscale 7:1403–1410. https://doi.org/10.1039/C4NR05954A10.1039/C4NR05954A ↗

23. Chen J, Zhao JX (2012) Upconversion nanomaterials: synthesis, mechanism, and applications in sensing. Sensors 12:2414–2435. https://doi.org/10.3390/S12030241410.3390/S120302414 ↗

24. Hong E, Liu L, Bai L, Xia C, Gao L, Zhang L, Wang B (2019) Control synthesis, subtle surface modification of rare-earth-doped upconversion nanoparticles and their applications in cancer diagnosis and treatment. Mater Sci Eng C 105:110097. https://doi.org/10.1016/J.MSEC.2019.11009710.1016/J.MSEC.2019.110097 ↗

25. Gee A, Xu X (2018) Surface functionalisation of upconversion nanoparticles with different moieties for biomedical applications. Surfaces 1:96–121. https://doi.org/10.3390/SURFACES101000910.3390/SURFACES1010009 ↗

26. Lin C, Berry MT, Anderson R, Smith S, May PS (2009) Highly luminescent NIR-to-visible upconversion thin films and monoliths requiring no high-temperature treatment. Chem Mater 21:3406–3413. https://doi.org/10.1021/CM901094M10.1021/CM901094M ↗

27. Auzel F (2004) Upconversion and anti-stokes processes with f and d ions in solids. Chem Rev 104:139–173. https://doi.org/10.1021/CR020357G10.1021/CR020357G ↗

28. Chivian JS, Case WE, Eden DD (1979) The photon avalanche: a new phenomenon in Pr3+-based infrared quantum counters. Appl Phys Lett 35:124–125. https://doi.org/10.1063/1.9104410.1063/1.91044 ↗

29. Arai MS, de Camargo ASS (2021) Exploring the use of upconversion nanoparticles in chemical and biological sensors: from surface modifications to point-of-care devices. Nanoscale Adv 3:5135–5165. https://doi.org/10.1039/D1NA00327E10.1039/D1NA00327E ↗

30. Haase M, Schäfer H (2011) Upconverting nanoparticles. Angew Chemie - Int Ed 50:5808–5829. https://doi.org/10.1002/ANIE.20100515910.1002/ANIE.201005159 ↗

31. Yu Z, Eich C, Cruz LJ (2020) Recent advances in rare-earth-doped nanoparticles for NIR-II imaging and cancer theranostics. Front Chem 8:496. https://doi.org/10.3389/FCHEM.2020.0049610.3389/FCHEM.2020.00496 ↗

32. Sedlmeier A, Gorris HH (2015) Surface modification and characterization of photon-upconverting nanoparticles for bioanalytical applications. Chem Soc Rev 44:1526–1560. https://doi.org/10.1039/C4CS00186A10.1039/C4CS00186A ↗

33. Tan H, Yu L, Gao F, Liao W, Wang W, Zeng W (2013) Surface modification: how nanoparticles assemble to molecular imaging probes. J Nanoparticle Res 15:2100. https://doi.org/10.1007/S11051-013-2100-910.1007/S11051-013-2100-9 ↗

34. Zhang D, Peng R, Liu W, Donovan MJ, Wang L, Ismail I, Li J, Li J, Qu F, Tan W (2021) Engineering DNA on the surface of upconversion nanoparticles for bioanalysis and therapeutics. ACS Nano 15:17257–17274. https://doi.org/10.1021/ACSNANO.1C0803610.1021/ACSNANO.1C08036 ↗

35. González-Béjar M, Francés-Soriano L, Pérez-Prieto J (2016) Upconversion nanoparticles for bioimaging and regenerative medicine. Front Bioeng Biotechnol 4:47. https://doi.org/10.3389/FBIOE.2016.0004710.3389/FBIOE.2016.00047 ↗

36. Chatterjee DK, Rufaihah AJ, Zhang Y (2008) Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29:937–943. https://doi.org/10.1016/J.BIOMATERIALS.2007.10.05110.1016/J.BIOMATERIALS.2007.10.051 ↗

37. Mello GPC, Simões EFC, Crista DMA, Leitão JMM, Pinto da Silva L, Esteves da Silva JCG (2019) Glucose sensing by fluorescent nanomaterials. Crit Rev Anal Chem 49:542–552. https://doi.org/10.1080/10408347.2019.156598410.1080/10408347.2019.1565984 ↗

38. Liu Y, Tu D, Zheng W, Lu L, You W, Zhou S, Huang P, Li R, Chen X (2018) A strategy for accurate detection of glucose in human serum and whole blood based on an upconversion nanoparticles-polydopamine nanosystem. Nano Res 11:3164–3174. https://doi.org/10.1007/S12274-017-1721-110.1007/S12274-017-1721-1 ↗

39. Ali M, Sajid M, Khalid MAU, Kim SW, Lim JH, Huh D, Choi KH (2020) A fluorescent lateral flow biosensor for the quantitative detection of vaspin using upconverting nanoparticles. Spectrochim Acta - Part A Mol Biomol Spectrosc 226:117610. https://doi.org/10.1016/J.SAA.2019.11761010.1016/J.SAA.2019.117610 ↗

40. Martiskainen I, Juntunen E, Salminen T, Vuorenpää K, Bayoumy S, Vuorinen T, Khanna N, Pettersson K, Batra G, Talha SM (2021) Double-antigen lateral flow immunoassay for the detection of anti-hiv-1 and-2 antibodies using upconverting nanoparticle reporters. Sensors (Switzerland) 21:1–17. https://doi.org/10.3390/S2102033010.3390/S21020330 ↗

41. Fang RH, Hu CMJ, Luk BT, Gao W, Copp JA, Tai Y, O’Connor DE, Zhang L (2014) Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14:2181–2188. https://doi.org/10.1021/NL500618U10.1021/NL500618U ↗

42. Fang H, Li M, Liu Q, Gai Y, Yuan L, Wang S, Zhang X, Ye M, Zhang Y, Gao M, Lan X, Hou Y (2020) Ultra-sensitive nanoprobe modified with tumor cell membrane for UCL/MRI/PET multimodality precise imaging of triple-negative breast cancer. Nano-Micro Lett 12:62. https://doi.org/10.1007/S40820-020-0396-410.1007/S40820-020-0396-4 ↗

43. Kamaraj N, Sundaresan S, Devaraj A (2017) DDA loaded PCL nanoparticles enhances the oral bioavailability of DDA in diabetes induced experimental rats. Int J Pharm Pharm Sci 9:198. https://doi.org/10.22159/IJPPS.2017V9I4.1686010.22159/IJPPS.2017V9I4.16860 ↗

44. Norpi ASM, Nordin ML, Ahmad N, Katas H, Fuaad AAHA, Sukri A, Marasini N, Azmi F (2022) New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus. Asian J Pharm Sci 17:435–446. https://doi.org/10.1016/J.AJPS.2022.04.00210.1016/J.AJPS.2022.04.002 ↗

45. Dong S, Ma S, Chen H, Tang Z, Song W, Deng M (2022) Nucleobase-crosslinked poly(2-oxazoline) nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy. Asian J Pharm Sci 17:571–582. https://doi.org/10.1016/J.AJPS.2022.04.00610.1016/J.AJPS.2022.04.006 ↗

46. Liang G, Wang H, Shi H, Wang H, Zhu M, Jing A, Li J, Li G (2020) Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment. J Nanobiotechnology 18:154. https://doi.org/10.1186/S12951-020-00713-310.1186/S12951-020-00713-3 ↗

47. Jalani G, Tam V, Vetrone F, Cerruti M (2018) Seeing, targeting and delivering with upconverting nanoparticles. J Am Chem Soc 140:10923–10931. https://doi.org/10.1021/JACS.8B0397710.1021/JACS.8B03977 ↗

48. Chu H, Cao T, Dai G, Liu B, Duan H, Kong C, Tian N, Hou D, Sun Z (2021) Recent advances in functionalized upconversion nanoparticles for light-activated tumor therapy. RSC Adv 11:35472–35488. https://doi.org/10.1039/D1RA05638G10.1039/D1RA05638G ↗

49. Yan J, Li C, Liu J (2021) Remotely ameliorating blood glucose levels in type 2 diabetes via a near-infrared laser. Adv Funct Mater 31:2007215. https://doi.org/10.1002/ADFM.20200721510.1002/ADFM.202007215 ↗

50. Wang C, Cheng L, Liu Z (2013) Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics 3:317–330. https://doi.org/10.7150/THNO.528410.7150/THNO.5284 ↗

51. Feng C, Zhu D, Chen L, Lu Y, Liu J, Kim NY, Liang S, Zhang X, Lin Y, Ma Y, Dong C (2019) Targeted delivery of chlorin E6 via redox sensitive diselenide-containing micelles for improved photodynamic therapy in cluster of differentiation 44-overexpressing breast cancer. Front Pharmacol 10:369. https://doi.org/10.3389/FPHAR.2019.0036910.3389/FPHAR.2019.00369 ↗

52. Chen X, Zhao Z, Jiang M, Que D, Shi S, Zheng N (2013) Preparation and photodynamic therapy application of NaYF4:Yb, Tm-NaYF4:Yb, Er multifunctional upconverting nanoparticles. New J Chem 37:1782–1788. https://doi.org/10.1039/C3NJ00065F10.1039/C3NJ00065F ↗

53. Dibaba ST, Xie Y, Xi W, Bednarkiewicz A, Ren W, Sun L (2022) Nd3+-sensitized upconversion nanoparticle coated with antimony shell for bioimaging and photothermal therapy in vitro using single laser irradiation. J Rare Earths 40:862–869. https://doi.org/10.1016/J.JRE.2021.05.01510.1016/J.JRE.2021.05.015 ↗

54. Nguyen PD, Son SJ, Min J (2014) Upconversion nanoparticles in bioassays, optical imaging and therapy. J Nanosci Nanotechnol 14:157–174. https://doi.org/10.1166/JNN.2014.889410.1166/JNN.2014.8894 ↗

55. Gong Y, Zheng Y, Jin B, You M, Wang J, Li XJ, Lin M, Xu F, Li F (2019) A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing. Talanta 201:126–133. https://doi.org/10.1016/J.TALANTA.2019.03.10510.1016/J.TALANTA.2019.03.105 ↗

56. Lin M, Gao Y, Hornicek F, Xu F, Lu TJ, Amiji M, Duan Z (2015) Near-infrared light activated delivery platform for cancer therapy. Adv Colloid Interface Sci 226:123–137. https://doi.org/10.1016/J.CIS.2015.10.00310.1016/J.CIS.2015.10.003 ↗

57. Lai WF, Rogach AL, Wong WT (2017) Molecular design of upconversion nanoparticles for gene delivery. Chem Sci 8:7339–7358. https://doi.org/10.1039/C7SC02956J10.1039/C7SC02956J ↗

58. Jiang S, Zhang Y, Lim KM, Sim EKW, Ye L (2009) NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA. Nanotechnology 20:155101. https://doi.org/10.1088/0957-4484/20/15/15510110.1088/0957-4484/20/15/155101 ↗

59. Lin M, Gao Y, Diefenbach TJ, Shen JK, Hornicek FJ, Il PY, Xu F, Lu TJ, Amiji M, Duan Z (2017) Facial layer-by-layer engineering of upconversion nanoparticles for gene delivery: near-infrared-initiated fluorescence resonance energy transfer tracking and overcoming drug resistance in ovarian cancer. ACS Appl Mater Interfaces 9:7941–7949. https://doi.org/10.1021/ACSAMI.6B1532110.1021/ACSAMI.6B15321 ↗

60. Chan MH, Chen SP, Chen CW, Chan YC, Lin RJ, Tsai DP, Hsiao M, Chung RJ, Chen X, Liu RS (2018) Single 808 nm laser treatment comprising photothermal and photodynamic therapies by using gold nanorods hybrid upconversion particles. J Phys Chem C 122:2402–2412. https://doi.org/10.1021/ACS.JPCC.7B1097610.1021/ACS.JPCC.7B10976 ↗

61. Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:535–545. https://doi.org/10.1038/NRC189410.1038/NRC1894 ↗

62. Ding B, Shao S, Yu C, Teng B, Wang M, Cheng Z, Wong KL, Ma P, Lin J (2018) Large-pore mesoporous-silica-coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy. Adv Mater 30:e1802479. https://doi.org/10.1002/ADMA.20180247910.1002/ADMA.201802479 ↗

63. Song W, Kuang J, Li CX, Zhang M, Zheng D, Zeng X, Liu C, Zhang XZ (2018) Enhanced immunotherapy based on photodynamic therapy for both primary and lung metastasis tumor eradication. ACS Nano 12:1978–1989. https://doi.org/10.1021/ACSNANO.7B0911210.1021/ACSNANO.7B09112 ↗

64. Xu J, Xu L, Wang C, Yang R, Zhuang Q, Han X, Dong Z, Zhu W, Peng R, Liu Z (2017) Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer. ACS Nano 11:4463–4474. https://doi.org/10.1021/ACSNANO.7B0071510.1021/ACSNANO.7B00715 ↗

65. Wang J, Qi J, Jin F, You Y, Du Y, Liu D, Xu X, Chen M, Shu G, Zhu L, Ying X, Ji J, Li W, Du Y (2022) Spatiotemporally light controlled “drug-free” macromolecules via upconversion-nanoparticle for precise tumor therapy. Nano Today 42:. https://doi.org/10.1016/J.NANTOD.2021.10136010.1016/J.NANTOD.2021.101360 ↗

66. Aghajanzadeh M, Zamani M, Kouchi FR, Eixenberger J, Shirini D, Estrada D, Shirini F (2022) Synergic antitumor effect of photodynamic therapy and chemotherapy mediated by nano drug delivery systems. Pharmaceutics 14:322. https://doi.org/10.3390/PHARMACEUTICS1402032210.3390/PHARMACEUTICS14020322 ↗

67. Sharma P, Allison JP (2015) The future of immune checkpoint therapy. Science 348:56–61. https://doi.org/10.1126/SCIENCE.AAA817210.1126/SCIENCE.AAA8172 ↗

68. Topalian SL, Taube JM, Anders RA, Pardoll DM (2016) Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer 16:275–287. https://doi.org/10.1038/NRC.2016.3610.1038/NRC.2016.36 ↗

69. Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, Tian T, Wei Z, Madan S, Sullivan RJ, Boland G, Flaherty K, Herlyn M, Ruppin E (2018) Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med 24:1545–1549. https://doi.org/10.1038/S41591-018-0157-910.1038/S41591-018-0157-9 ↗

70. Morrison AH, Diamond MS, Hay CA, Byrne KT, Vonderheide RH (2020) Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity. Proc Natl Acad Sci U S A 117:8022–8031. https://doi.org/10.1073/PNAS.191897111710.1073/PNAS.1918971117 ↗

71. Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, Ostberg JR, Blanchard MS, Kilpatrick J, Simpson J, Kurien A, Priceman SJ, Wang X, Harshbarger TL, D’Apuzzo M, Ressler JA, Jensen MC, Barish ME, Chen M, Portnow J, Forman SJ, Badie B (2016) Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med 375:2561–2569. https://doi.org/10.1056/NEJMOA161049710.1056/NEJMOA1610497 ↗

72. Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, Komanduri KV, Lin Y, Jain N, Daver N, Westin J, Gulbis AM, Loghin ME, De Groot JF, Adkins S, Davis SE, Rezvani K, Hwu P, Shpall EJ (2018) Chimeric antigen receptor T-cell therapy-assessment and management of toxicities. Nat Rev Clin Oncol 15:47–62. https://doi.org/10.1038/NRCLINONC.2017.14810.1038/NRCLINONC.2017.148 ↗

73. Fraietta JA, Lacey SF, Orlando EJ, Pruteanu-Malinici I, Gohil M, Lundh S, Boesteanu AC, Wang Y, O’connor RS, Hwang WT, Pequignot E, Ambrose DE, Zhang C, Wilcox N, Bedoya F, Dorfmeier C, Chen F, Tian L, Parakandi H, Gupta M, Young RM, Johnson FB, Kulikovskaya I, Liu L, Xu J, Kassim SH, Davis MM, Levine BL, Frey NV, Siegel DL, Huang AC, Wherry EJ, Bitter H, Brogdon JL, Porter DL, June CH, Melenhorst JJ (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med 24:563–571. https://doi.org/10.1038/S41591-018-0010-110.1038/S41591-018-0010-1 ↗

74. Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22. https://doi.org/10.1038/NRC125210.1038/NRC1252 ↗

75. Van Gorp H, Lamkanfi M (2019) The emerging roles of inflammasome-dependent cytokines in cancer development. EMBO Rep 20:e47575. https://doi.org/10.15252/EMBR.20184757510.15252/EMBR.201847575 ↗

76. Qiao J, Fu YX (2020) Cytokines that target immune killer cells against tumors. Cell Mol Immunol 17:722–727. https://doi.org/10.1038/S41423-020-0481-010.1038/S41423-020-0481-0 ↗

77. Napolitano S, Brancaccio G, Argenziano G, Martinelli E, Morgillo F, Ciardiello F, Troiani T (2018) It is finally time for adjuvant therapy in melanoma. Cancer Treat Rev 69:101–111. https://doi.org/10.1016/J.CTRV.2018.06.00310.1016/J.CTRV.2018.06.003 ↗

78. Tsujimura K, Ikehara Y, Nagata T, Koide Y, Kojima N (2009) Induction of anti-tumor immune responses with oligomannose-coated liposomes targeting to peritoneal macrophages. Procedia Vaccinol 1:127–134. https://doi.org/10.1016/J.PROVAC.2009.07.02410.1016/J.PROVAC.2009.07.024 ↗

79. Mettenbrink EM, Yang W, Wilhelm S (2022) Bioimaging with upconversion nanoparticles. Adv Photonics Res 3:220009810.1002/adpr.202200098 ↗

80. Gnach A, Lipinski T, Bednarkiewicz A, Rybka J, Capobianco JA (2015) Upconverting nanoparticles: assessing the toxicity. Chem Soc Rev 44:1561–158410.1039/C4CS00177J ↗

81. Xiong L, Yang T, Yang Y, Xu C, Li F (2010) Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 31:7078–708510.1016/j.biomaterials.2010.05.065 ↗

82. Xing H et al (2012) A NaYbF4: Tm3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 33:5384–539310.1016/j.biomaterials.2012.04.002 ↗

83. Cao T et al (2011) High-quality water-soluble and surface-functionalized upconversion nanocrystals as luminescent probes for bioimaging. Biomaterials 32:2959–296810.1016/j.biomaterials.2010.12.050 ↗

84. Agraharam G, Saravanan N, Girigoswami A, Girigoswami K (2022) Future of Alzheimer’s disease: nanotechnology-based diagnostics and therapeutic approach. Bionanoscience 12:1002–1017. https://doi.org/10.1007/S12668-022-00998-810.1007/S12668-022-00998-8 ↗

85. Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS (2012) Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol 60:1207–1216. https://doi.org/10.1016/J.JACC.2012.03.07410.1016/J.JACC.2012.03.074 ↗

86. Menezes G, Menez P, Meneze C (2011) Nanoscience in diagnostics: a short review. Internet J Med Updat - EJournal 6. https://doi.org/10.4314/IJMU.V6I1.6397110.4314/IJMU.V6I1.63971 ↗